Supply Chain Archives

04/29/2025
Optimizing Cryopreservation for Leukapheresis: Advancing Cell and Gene Therapy Supply Chains
The supply chain for fresh leukapheresis is one of the most complex logistical challenges in cell and gene therapy (CGT). As a critical starting material, leukapheresis must be collected from donors, processed, and transported within a limited time window. These challenges increase variability and risk, ultimately impacting the success of advanced therapies. Alexandre Michaux, Process Development & MSAT Manager at IntegriCell™ , recently presented his work on the development of an automated cryopreservation process for leukapheresis in a Poster Presentation at Advanced Therapies Congress in London.
04/22/2025
Advancing Standardization in Cell and Gene Therapy Supply Chains
The future of cell and gene therapy depends not only on scientific advancements but also on the efficiency and reliability of its supply chain. In a recent panel discussion at Advanced Therapies Congress in London, Mark Flower, VP of Business Development, Cryopreservation at Cryoport Systems, explored the critical need for standardization, the challenges in achieving it, and the opportunities to improve logistics, manufacturing, and delivery systems.
03/21/2025
Optimizing ATMP Cryopreservation: How IntegriCell™ Services in Belgium Ensure Cell Viability and Supply Chain Integrity
Cryopreservation is quickly becoming a critical yet often underestimated component of the Advanced Therapy Medicinal Product (ATMP) supply chain. The success of cell-based therapies depends on maintaining cell viability, stability, and consistency, yet variability in cryopreservation methods has compromised therapeutic outcomes.
02/04/2025
Advancing Patient Outcomes Through Integrated Supply Chain Solutions
The landscape of advanced therapies is consistently shifting, requiring a seamless, high-quality supply chain to ensure the safe and effective delivery of life-saving treatments. In a recent interview at Advanced Therapies Week, Cryoport Systems leaders shared insights into how their integrated approach is shaping the future of supply chain management for the biopharmaceutical industry.
02/04/2025
World Cancer Day: Advancing the Fight with Cell and Gene Therapies
Each year on World Cancer Day, the global community comes together to raise awareness, encourage prevention, and support those affected by cancer. It is a day of reflection, a time to recognize the immense progress that has been made in cancer research while acknowledging the work that still lies ahead.
12/11/2024
Reflecting on 2024: A Year of Groundbreaking Achievements
As we close out 2024, we reflect on a year marked by transformative milestones and significant growth at Cryoport Systems. This year, we took bold strides to redefine the future of supply chain solutions for life sciences.
07/16/2024
IntegriCell™: Extending Cell Viability with Manufacture-ready Cryopreserved Leukopaks
During the COVID-19 pandemic, the restrictions on transportation and travel negatively impacted patients' access to life-saving treatments and support.
02/06/2024
Enabling the Outcome with Cryoport Systems
Cryoport Systems entered the market over two decades ago to support the logistics processes of life sciences organizations. As industry demands evolved, our logistics capabilities expanded into a robust platform of supply chain management offerings.Categories
- All (58)
- Industry Insights (16)
- Managing the Cold Chain (16)
- Navigating Logistics (21)
- Patient Access and Awareness (4)